Drug Shortage Report for TEVA-OLMESARTAN / HCTZ
| Report ID | 65346 |
| Drug Identification Number | 02443139 |
| Brand name | ACT OLMESARTAN HCT |
| Common or Proper name | OLMESARTAN HCTZ |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL |
| Strength(s) | 25MG 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2018-10-22 |
| Estimated end date | Unknown |
| Actual end date | 2020-06-08 |
| Shortage status | Resolved |
| Updated date | 2020-06-11 |
| Company comments | Item is discontined |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-06-11 | French | Compare |
| v6 | 2020-06-11 | English | Compare |
| v5 | 2019-01-08 | French | Compare |
| v4 | 2019-01-08 | English | Compare |
| v3 | 2018-10-23 | English | Compare |
| v2 | 2018-10-22 | French | Compare |
| v1 | 2018-10-22 | English | Compare |
Showing 1 to 7 of 7